La Jolla Pharma Announces Financial Results For The Three And Nine Months Ended September 30, 2016 And Recent Corporate Progress

Published: Nov 04, 2016

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported financial results for the three and nine months ended September 30, 2016 and recent corporate progress.

Back to news